Showing results (11-20 of 40) with videos related to

Sort By:
Pageof 4
European Journal of Investigation in Health, Psychology and Education|October 28, 2021
The Relationship between Body Dissatisfaction and Eating Disorder Symptoms in Young Women Aspiring Fashion Models: The Mediating Role of StressSabrina Castellano, Agostino Rizzotto, Sergio Neri, et al.
International Journal of Molecular Medicine|March 27, 2012
Evaluation of circulating CD4+CD25+ and liver-infiltrating Foxp3+ cells in HCV-associated liver diseaseAlfredo Amoroso, Fabio D'Amico, Maria Consolo, et al.
Annals of Saudi Medicine|August 3, 2011
Relationship between circulating interleukin-10 and histological features in patients with chronic C hepatitisCosimo Marcello Bruno, Maria Valenti, Gaetano Bertino, et al.
Molecular Medicine Reports|April 9, 2013
Neopterin: a potential marker in chronic peripheral arterial diseaseSalvatore Santo Signorelli, Massimiliano Anzaldi, Valerio Fiore, et al.
World Journal of Gastroenterology|April 28, 2004
Plasma erythropoietin levels in anaemic and non-anaemic patients with chronic liver diseasesCosimo Marcello Bruno, Sergio Neri, Claudio Sciacca, et al.
Acta Histochemica|July 17, 2009
Liver immunolocalization and plasma levels of MMP-9 in non-alcoholic steatohepatitis (NASH) and hepatitis C infectionFabio D'Amico, Maria Consolo, Alfredo Amoroso, et al.
Clinical Therapeutics|December 5, 2002
Controlled clinical trial to assess the response of recent heroin abusers with chronic hepatitis C virus infection to treatment with interferon alpha-n2bSergio Neri, Cosimo M Bruno, Giuseppe Abate, et al.
World Journal of Gastroenterology|November 24, 2011
L-carnitine supplementation improves hematological pattern in patients affected by HCV treated with Peg interferon-α 2b plus ribavirinMichele Malaguarnera, Marco Vacante, Maria Giordano, et al.
Archives of Gerontology and Geriatrics|July 31, 2007
Acetyl L-carnitine (ALC) treatment in elderly patients with fatigueMichele Malaguarnera, Maria Pia Gargante, Erika Cristaldi, et al.
Hepatitis Monthly|November 17, 2011
Rosuvastatin reduces nonalcoholic fatty liver disease in patients with chronic hepatitis C treated with α-interferon and ribavirin: Rosuvastatin reduces NAFLD in HCV patientsMichele Malaguarnera, Marco Vacante, Cristina Russo, et al.
Pageof 4